Showing results (1401-1410 of 2,426) with videos related to

Sort By:
Pageof 243
Toxicology and Industrial Health|May 1, 1990
An evaluation of the developmental toxicity of 2,4-pentanedione in the Fischer 344 rat by vapour exposureR W Tyl, B Ballantyne, I M Pritts, et al.
Forensic Science International|September 6, 2005
Inference of human geographic origins using Alu insertion polymorphismsDavid A Ray, Jerilyn A Walker, Ashley Hall, et al.
Eye (London, England)|January 1, 1995
Comparison of visual assessment tests in multiply handicapped childrenR T Mackie, D L McCulloch, K J Saunders, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1994
Evaluation of exposure to water aerosol or air by nose-only or whole-body inhalation procedures for CD-1 mice in developmental toxicity studiesR W Tyl, B Ballantyne, L C Fisher, et al.
Thrombosis Research|June 11, 2013
Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective studyAaron R Folsom, Pamela L Lutsey, Nicholas S Roetker, et al.
Atherosclerosis|February 18, 2014
Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiencyIlvira M Khan, Xiao-Yuan Dai Perrard, Jerry L Perrard, et al.
Journal of the American College of Cardiology|March 8, 2023
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616Christie M Ballantyne, Puja Banka, Gustavo Mendez, et al.
Journal of the American College of Cardiology|March 18, 2025
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in HypertriglyceridemiaChristie M Ballantyne, Daniel Gaudet, Robert S Rosenson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Heterogeneity in Lipoprotein(a) Profile Changes Across the Menopausal TransitionCatherine A Palmer, Christy L Avery, Christie M Ballantyne, et al.
Pageof 243